Travere Therapeutics, Inc.

SEC 4 · Filed

0001698262-25-000005Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Dec 24, 2025

Exercise or conversion by ROTE WILLIAM E.

Security
Employee stock option (right to buy)
Code
M
Shares
60,000
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2025-12-24",
  "direction": "D",
  "exercise_price": "20.61",
  "expiration": "2027-02-13",
  "footnotes": {
    "F4": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001698262",
      "name": "ROTE WILLIAM E.",
      "roles": [
        "officer"
      ],
      "title": "Chief Research Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "0",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Employee stock option (right to buy)",
  "shares": "60000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "60000"
}
Insider transactionsEvent date Dec 24, 2025

Sale by ROTE WILLIAM E.

Security
Common Stock
Code
S
Shares
60,000
Price per share
40.10Reported 40.103
Structured facts
{
  "code": "S",
  "date": "2025-12-24",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "This sale was made pursuant to a written plan adopted on May 29, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option grant to the Reporting Person on February 13, 2017, with an expiration date of February 13, 2027.",
    "F3": "The weighted average sale price for the transaction reported was $40.103, and the range of prices were between $38.00 and $42.07. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided."
  },
  "owners": [
    {
      "cik": "0001698262",
      "name": "ROTE WILLIAM E.",
      "roles": [
        "officer"
      ],
      "title": "Chief Research Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "101443",
  "price": "40.103",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "60000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Dec 24, 2025

Exercise or conversion by ROTE WILLIAM E.

Security
Common Stock
Code
M
Shares
60,000
Price per share
20.61
Structured facts
{
  "code": "M",
  "date": "2025-12-24",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Includes 607 shares of Common Stock that were acquired by the Reporting Person on May 30, 2025, and 595 shares of Common Stock that were acquired by the Reporting Person on November 28, 2025, pursuant to the Issuer\u0027s Employee Stock Purchase Plan."
  },
  "owners": [
    {
      "cik": "0001698262",
      "name": "ROTE WILLIAM E.",
      "roles": [
        "officer"
      ],
      "title": "Chief Research Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "161443",
  "price": "20.61",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "60000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}